Published in J Vis Exp on April 29, 2015
Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens. J Control Release (2015) 0.84
Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.78
Designer vaccine nanodiscs for personalized cancer immunotherapy. Nat Mater (2016) 0.78
Toward a Single-Dose Vaccination Strategy with Self-Encapsulating PLGA Microspheres. Adv Healthc Mater (2017) 0.77
Restoring function in exhausted CD8 T cells during chronic viral infection. Nature (2005) 28.04
Phenotypic analysis of antigen-specific T lymphocytes. Science (1996) 24.26
T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66
Preferential localization of effector memory cells in nonlymphoid tissue. Science (2001) 14.22
Follicular helper CD4 T cells (TFH). Annu Rev Immunol (2011) 12.50
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods (2003) 11.81
T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol (2008) 11.65
Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology (1968) 11.20
Cryo-electron microscopy of vitrified specimens. Q Rev Biophys (1988) 11.14
Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity (2007) 10.83
mTOR regulates memory CD8 T-cell differentiation. Nature (2009) 10.07
Regulation of adaptive immunity by the innate immune system. Science (2010) 8.00
Tricine-SDS-PAGE. Nat Protoc (2006) 7.89
A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods (1983) 6.71
Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature (2006) 5.54
Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol (2005) 4.59
Patterns of lymphatic drainage in the adult laboratory rat. J Anat (1971) 4.15
Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci (2007) 4.00
Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol (2007) 3.75
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. J Clin Invest (2005) 3.11
Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol (2008) 2.97
A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab Anim (NY) (2005) 2.78
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nat Mater (2011) 2.71
Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion. Nat Med (2013) 2.65
Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer. Proc Natl Acad Sci U S A (2008) 2.20
Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol Cell Biol (2000) 1.98
Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction. Proc Natl Acad Sci U S A (2012) 1.84
Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes. Clin Cancer Res (2001) 1.79
Engineering nano- and microparticles to tune immunity. Adv Mater (2012) 1.75
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nat Med (2010) 1.71
Structure-based programming of lymph-node targeting in molecular vaccines. Nature (2014) 1.60
Silver staining of proteins in polyacrylamide gels. Nat Protoc (2006) 1.58
Vesicle-micelle transition of phosphatidylcholine and octyl glucoside elucidated by cryo-transmission electron microscopy. Biophys J (1989) 1.53
Nanoparticle vaccines. Vaccine (2013) 1.51
Engineering synthetic vaccines using cues from natural immunity. Nat Mater (2013) 1.48
Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses. J Clin Invest (2012) 1.37
Detection of intracellular cytokines by flow cytometry. Curr Protoc Immunol (2007) 1.32
Monitoring the trafficking of adoptively transferred antigen- specific CD8-positive T cells in vivo, using noninvasive luminescence imaging. Hum Gene Ther (2007) 1.23
Memories that last forever: strategies for optimizing vaccine T-cell memory. Blood (2009) 1.23
Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues. AAPS PharmSciTech (2005) 1.22
Biomaterials for nanoparticle vaccine delivery systems. Pharm Res (2014) 1.09
Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination. Sci Transl Med (2013) 1.09
Imaging CD8+ T cell dynamics in vivo using a transgenic luciferase reporter. Int Immunol (2007) 1.09
Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis. J Control Release (2013) 1.08
In vitro and in vivo bioluminescence reporter gene imaging of human embryonic stem cells. J Vis Exp (2008) 1.06
Manual restraint and common compound administration routes in mice and rats. J Vis Exp (2012) 1.03
Induction and measurement of cytotoxic T lymphocyte activity. Curr Protoc Immunol (2006) 1.01
PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution. J Control Release (2011) 0.96
Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery. ACS Nano (2012) 0.93
Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and the rate and type of T cell response. J Control Release (2012) 0.81
PLA and PLGA microspheres of beta-galactosidase: Effect of formulation factors on protein antigenicity and immunogenicity. J Biomed Mater Res A (2004) 0.81
Isolation and th17 differentiation of naïve CD4 T lymphocytes. J Vis Exp (2013) 0.81
Visualization of the interstitial cells of cajal (ICC) network in mice. J Vis Exp (2011) 0.79
Cell-based flow cytometry assay to measure cytotoxic activity. J Vis Exp (2013) 0.79
Combatting infectious diseases; nanotechnology as a platform for rational vaccine design. Adv Drug Deliv Rev (2014) 0.79
The use of fluorescent target arrays for assessment of T cell responses in vivo. J Vis Exp (2014) 0.76